Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vivo engineering of murine T cells using the evolved adeno-associated virus variant Ark313

Immunity(2025)10.1016/j.immuni.2025.01.009Source: DataRank Database

In vivo engineering of murine T cells using the evolved adeno-associated virus variant Ark313 is a research paper published in Immunity (2025). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 27.04)OA: hybridTopics (81)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (28)

Charlotte H. Wang ORCID,Jonathan Ark ORCID,Chang Liu ORCID,Sylvanie Clouden,Anita Qualls ORCID

Live enrichment

PubMed:39909036 OpenAlex:https://openalex.org/W4407135498

National Institutes of Health

Grant: R01HL089221

National Institutes of Health

Grant: R01GM127708

Swedish Research Council

Grant: unidentified

unidentified

Swedish Society for Medical Research

Vetenskapsrådet

Parker Institute for Cancer Immunotherapy

CRI

FWCI

27.04

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.immuni.2025.01.009

publisherhttps://doi.org/10.1016/j.immuni.2025.01.009

publisherhttps://api.elsevier.com/content/article/PII:S1074761325000342?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761325000342?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39909036

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchRNA Interference and Gene Delivery0301 basic medicine03 medical and health sciencesAnimalsDependovirusMiceTransgenesGenetic VectorsGenetic EngineeringT-LymphocytesMice, Inbred C57BLGene EditingCD8-Positive T-LymphocytesMice, TransgenicCD4-Positive T-LymphocytesHumansIntegrasesCapsid Proteins

MeSH Terms

Gene EditingDependovirusAnimalsGenetic EngineeringGenetic VectorsHumansImmunotherapyMice, Inbred C57BLMice, TransgenicT-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesTransgenesIntegrasesCapsid ProteinsMice

Keywords

BiologyTransgeneIn vivoAdeno-associated virusCre recombinaseCD8Gene deliveryImmunotherapyMolecular biologyReporter geneVirologyCell biologyGenetic enhancementGenetically modified mouseImmune systemGeneImmunologyVector (molecular biology)Recombinant DNAGeneticsGene expressionAAVimmune therapygene targetingT Cell EngineeringKnockinIn vivo DeliveryIn Vivo Gene EditingArk313Mouse T cellsGene EditingCD4-Positive T-LymphocytesIntegrasesT-LymphocytesGenetic VectorsMice, TransgenicDependovirusCD8-Positive T-LymphocytesMice, Inbred C57BLMiceAnimalsHumansCapsid ProteinsTransgenesGenetic Engineering